Now is the time to address the Culture of Residential Aged Care Facilities to support Pharmacists in reducing psychotropic prescribing

Mouna Sawan; Timothy Chen; Phyo Kyaw Myint; Yun-Hee Jeon; Sarah Hilmer

doi:10.1111/ijpp.12501

Now is the time to address the Culture of Residential Aged Care Facilities to support Pharmacists in reducing psychotropic prescribing

Mouna Sawan (Corresponding Author), Timothy Chen, Phyo Kyaw Myint, Yun-Hee Jeon, Sarah Hilmer

Research output: Contribution to journal › Editorial › peer-review

1 Citation (Scopus)

Abstract

The high‐level use of psychotropic medicines, particularly antipsychotics, for the treatment of behavioural and psychological symptoms of dementia (BPSD) in residential aged care facilities (RACFs) is widely reported. The current estimates of the prevalence of psychotropic medicines in such facilities are high: 44% in the UK,1 61% in Australia2 and over 60% in the United States.3 Psychotropic medicines are recommended not to be used first‐line for the management of BPSD, and among residents with dementia are associated with significant adverse outcomes.3, 4 However, the use of these medicines remains high. They are often used outside of approved indications, for longer than recommended or at higher doses.

Original language	English
Pages (from-to)	404-405
Number of pages	2
Journal	International Journal of Pharmacy Practice
Volume	27
Issue number	5
Early online date	6 Sep 2019
DOIs	https://doi.org/10.1111/ijpp.12501
Publication status	Published - Oct 2019

Access to Document

10.1111/ijpp.12501Licence: Unspecified

Accepted Manuscript
This is the peer reviewed version of the following article: Sawan, M. , Chen, T. F., Myint, P. K., Jeon, Y. and Hilmer, S. N. (2019), Now is the time to address the Culture of Residential Aged Care Facilities to support Pharmacists in reducing psychotropic prescribing. Int J Pharm Pract, 27: 404-405. doi:10.1111/ijpp.12501, which has been published in final form at https://doi.org/10.1111/ijpp.12501. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions
Accepted author manuscript, 144 KBLicence: Unspecified

Cite this

@article{badeac3afc154cbca1bd18b7a16014ab,

title = "Now is the time to address the Culture of Residential Aged Care Facilities to support Pharmacists in reducing psychotropic prescribing",

abstract = "The high‐level use of psychotropic medicines, particularly antipsychotics, for the treatment of behavioural and psychological symptoms of dementia (BPSD) in residential aged care facilities (RACFs) is widely reported. The current estimates of the prevalence of psychotropic medicines in such facilities are high: 44% in the UK,1 61% in Australia2 and over 60% in the United States.3 Psychotropic medicines are recommended not to be used first‐line for the management of BPSD, and among residents with dementia are associated with significant adverse outcomes.3, 4 However, the use of these medicines remains high. They are often used outside of approved indications, for longer than recommended or at higher doses.",

author = "Mouna Sawan and Timothy Chen and Myint, {Phyo Kyaw} and Yun-Hee Jeon and Sarah Hilmer",

year = "2019",

month = oct,

doi = "10.1111/ijpp.12501",

language = "English",

volume = "27",

pages = "404--405",

journal = "International Journal of Pharmacy Practice",

issn = "0961-7671",

publisher = "John Wiley & Sons, Ltd (10.1111)",

number = "5",

}

TY - JOUR

T1 - Now is the time to address the Culture of Residential Aged Care Facilities to support Pharmacists in reducing psychotropic prescribing

AU - Sawan, Mouna

AU - Chen, Timothy

AU - Myint, Phyo Kyaw

AU - Jeon, Yun-Hee

AU - Hilmer, Sarah

PY - 2019/10

Y1 - 2019/10

N2 - The high‐level use of psychotropic medicines, particularly antipsychotics, for the treatment of behavioural and psychological symptoms of dementia (BPSD) in residential aged care facilities (RACFs) is widely reported. The current estimates of the prevalence of psychotropic medicines in such facilities are high: 44% in the UK,1 61% in Australia2 and over 60% in the United States.3 Psychotropic medicines are recommended not to be used first‐line for the management of BPSD, and among residents with dementia are associated with significant adverse outcomes.3, 4 However, the use of these medicines remains high. They are often used outside of approved indications, for longer than recommended or at higher doses.

AB - The high‐level use of psychotropic medicines, particularly antipsychotics, for the treatment of behavioural and psychological symptoms of dementia (BPSD) in residential aged care facilities (RACFs) is widely reported. The current estimates of the prevalence of psychotropic medicines in such facilities are high: 44% in the UK,1 61% in Australia2 and over 60% in the United States.3 Psychotropic medicines are recommended not to be used first‐line for the management of BPSD, and among residents with dementia are associated with significant adverse outcomes.3, 4 However, the use of these medicines remains high. They are often used outside of approved indications, for longer than recommended or at higher doses.

UR - http://www.mendeley.com/research/now-time-address-culture-residential-aged-care-facilities-support-pharmacists-reducing-psychotropic

U2 - 10.1111/ijpp.12501

DO - 10.1111/ijpp.12501

M3 - Editorial

VL - 27

SP - 404

EP - 405

JO - International Journal of Pharmacy Practice

JF - International Journal of Pharmacy Practice

SN - 0961-7671

IS - 5

ER -

Now is the time to address the Culture of Residential Aged Care Facilities to support Pharmacists in reducing psychotropic prescribing

Abstract

Access to Document

Other files and links

Fingerprint

Cite this